Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
54,247,348
-
Share change
-
-420,379
-
Total reported value
-
$7,295,659,971
-
Put/Call ratio
-
292%
-
Price per share
-
$134.65
-
Number of holders
-
319
-
Value change
-
-$66,672,908
-
Number of buys
-
145
-
Number of sells
-
141
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2017
As of 31 Dec 2017,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
319 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,247,348 shares.
The largest 10 holders included
PUTNAM INVESTMENTS LLC, FMR LLC, Vanguard Group Inc, BlackRock Inc., Bank of New York Mellon Corp, JPMORGAN CHASE & CO, Senator Investment Group LP, CADIAN CAPITAL MANAGEMENT, LP, RENAISSANCE TECHNOLOGIES LLC, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
319
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.